Search Results - "Di Felice, Giulia"

Effect of cancer on outcome of COVID-19 patients: a systematic review and meta-analysis of studies of unvaccinated patients by Di Felice, Giulia, Visci, Giovanni, Teglia, Federica, Angelini, Marco, Boffetta, Paolo

“…Since the beginning of the SARS-CoV-2 pandemic, cancer patients affected by COVID-19 have been reported to experience poor prognosis; however, a detailed…”
Get full text

Determinants of SARS-CoV-2 infection in Italian healthcare workers: a multicenter study by Boffetta, Paolo, Violante, Francesco, Durando, Paolo, De Palma, Giuseppe, Pira, Enrico, Vimercati, Luigi, Cristaudo, Alfonso, Icardi, Giancarlo, Sala, Emma, Coggiola, Maurizio, Tafuri, Silvio, Gattini, Vittorio, Apostoli, Pietro, Spatari, Giovanna

“…Healthcare workers (HCWs) are at increased risk of being infected with SARS-CoV-2, yet limited information is available on risk factors of infection. We pooled…”
Get full text

Difference in safety and humoral response to mRNA SARS-CoV-2 vaccines in patients with autoimmune neurological disorders: the ANCOVAX study by Giannoccaro, Maria Pia, Vacchiano, Veria, Leone, Marta, Camilli, Federico, Zenesini, Corrado, Panzera, Ivan, Balboni, Alice, Tappatà, Maria, Borghi, Annamaria, Salvi, Fabrizio, Lugaresi, Alessandra, Rinaldi, Rita, Di Felice, Giulia, Lodi, Vittorio, Lazzarotto, Tiziana, Liguori, Rocco

“…Background Assessing the safety of SARS-CoV-2 mRNA vaccines and the effect of immunotherapies on the seroconversion rate in patients with autoimmune…”
Get full text

Recent Advances in the Evaluation of Serological Assays for the Diagnosis of SARS-CoV-2 Infection and COVID-19 by Chiereghin, Angela, Zagari, Rocco Maurizio, Galli, Silvia, Moroni, Alessandra, Gabrielli, Liliana, Venturoli, Simona, Bon, Isabella, Rossini, Giada, Saracino, Ilaria Maria, Pavoni, Matteo, Lafratta, Silvia, Deni, Alessandro, Felici, Silvia, Borghi, Michele, Guerra, Luca, Raumer, Luigi, Lodi, Vittorio, Viale, Pierluigi, Attard, Luciano, Lazzarotto, Tiziana

“…Few data on the diagnostic performance of serological tests for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection are currently available…”
Get full text